- Forbes•3 hours ago
Donald Trump needed just 20 minutes to knock $24.6 billion in value from the nine biggest Big Pharma companies. That was the statistic bandied about recently when the president-elect, at a much-anticipated press conference, declared that pharmaceuticals are “getting away with murder.” That’s ironic, because investors targeting the sure-fire dividends of
- Zacks•4 hours ago
Eli Lilly and Company (LLY) and Incyte Corporation (INCY) announced that the FDA has extended the time to review the company's NDA for baricitinib for the treatment of rheumatoid arthritis (RA).
- Zacks•3 days ago
Eli Lilly and Company (LLY) announced that it has received a favorable ruling in a lawsuit against generic drugmaker Teva Pharmaceutical Industries Limited (TEVA) related to the infringement of a vitamin regimen patent for its cancer drug Alimta.
TEVA : Summary for Teva Pharmaceutical Industries - Yahoo Finance
Teva Pharmaceutical Industries Limited (TEVA)
NYSE - NYSE Delayed Price. Currency in USD
Add to watchlist
|Day's Range||33.86 - 34.47|
|52 Week Range||33.56 - 64.31|
Trade prices are not sourced from all markets
|PE Ratio (TTM)||22.69|
|Dividend & Yield||1.36 (4.00%)|
|1y Target Est||N/A|